Arkolith/Insider Trading/PRTK/Form 4

Bigham Michael

Exec. Chairman of the Board, DirectorParatek Pharmaceuticals, Inc. (PRTK) · full profile →Form 4 · filed Sep 21, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 21, 2023Disposed to issuer(D)1.1M——229K
Sep 21, 2023Disposed to issuer(D)229K——0
Feb 2, 2018Option exercise(M)23K$4.30$100K1.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 2, 2018Option exercise(M)23K—$00

Transaction Codes

D
Disposition to the issuer
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-019356) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML